....Yet the potential for conflicts of interest are enormous. Here is just one obvious example: BlackRock owns about 10% of AstraZeneca
, the pharmaceutical firm at the centre of a political storm when US rival Pfizer launched an unsuccessful £69bn bid in 2014. ...
[Read full article on Guardian
Thursday 6th of April 2017 12:42:10 PM